Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06253871
Title	A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Iambic Therapeutics, Inc
Indications	Advanced Solid Tumor
Therapies	IAM1363 IAM1363 + Trastuzumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 12 of 12 entries

Facility	Status	City	State	Zip	Country	Details
Cleveland Clinic	RECRUITING	Cleveland	Ohio	44195	United States	Details
Comprehensive Hematology Oncology	RECRUITING	Saint Petersburg	Florida	33709	United States	Details
Mary Crowley Cancer Research	RECRUITING	Dallas	Texas	75230	United States	Details
NEXT Oncology - Austin	RECRUITING	Austin	Texas	78758	United States	Details
NEXT Oncology - Dallas	RECRUITING	Dallas	Texas	75039	United States	Details
NEXT Oncology - Virginia Cancer Specialists	RECRUITING	Fairfax	Virginia	22031	United States	Details
OU Health Stephenson Cancer Center	RECRUITING	Oklahoma City	Oklahoma	73104	United States	Details
SCRI Oncology Partners	RECRUITING	Nashville	Tennessee	37203	United States	Details
START - Midwest Cancer Research Center	RECRUITING	Grand Rapids	Michigan	49546	United States	Details
START Mountain Region	RECRUITING	West Valley City	Utah	84119	United States	Details
University of Michigan	RECRUITING	Ann Arbor	Michigan	48109	United States	Details
USC Norris Comprehensive Cancer Center	RECRUITING	Los Angeles	California	90089	United States	Details

Showing 1 to 12 of 12 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field